Search research articles
Contact Us
Filters
Showing results (21-30 of 85) with videos related to
Page
of 9
Sort By:
Neurology
|
March 1, 1984
Renal function and therapeutic concentrations of phenytoin
D F Liponi, M E Winter, T N Tozer
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1987
Nonenzymatic bioreduction in rat liver and kidney of nitroxyl spin labels, potential contrast agents in magnetic resonance imaging
U G Eriksson, R C Brasch, T N Tozer
Journal of Chromatography
|
November 30, 1990
Simultaneous assay of pentachlorophenol and its metabolite, tetrachlorohydroquinone, by gas chromatography without derivatization
B G Reigner, J F Rigod, T N Tozer
Biochemical Pharmacology
|
July 1, 1976
Increased methotrexate toxicity due to concurrent probenecid administration
R E Kates, T N Tozer, D L Sorby
Pharmaceutical Research
|
August 1, 1992
Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouse
B G Reigner, J F Rigod, T N Tozer
Therapeutic Drug Monitoring
|
September 1, 1989
Time for phenytoin concentration to peak: consequences of first-order and zero-order absorption
D L McCauley, T N Tozer, M E Winter
Journal of Pharmaceutical Sciences
|
January 1, 1975
Nonliner tissue disposition: salicylic acid in rat brain
M A Gonzalez, T N Tozer, T T Chang
Journal of Pharmaceutical Sciences
|
September 1, 1994
Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents
A D McLeod, D R Friend, T N Tozer
Human & Experimental Toxicology
|
May 1, 1993
Pentachlorophenol carcinogenicity: extrapolation of risk from mice to humans
B G Reigner, F Y Bois, T N Tozer
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1982
Urine flow-dependence of theophylline renal clearance in man
D D Tang-Liu, T N Tozer, S Riegelman
Page
of 9
Search research articles
Search
Showing results (21-30 of 85) with videos related to
Sort By:
Page
of 9
Neurology
|
March 1, 1984
Renal function and therapeutic concentrations of phenytoin
D F Liponi, M E Winter, T N Tozer
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1987
Nonenzymatic bioreduction in rat liver and kidney of nitroxyl spin labels, potential contrast agents in magnetic resonance imaging
U G Eriksson, R C Brasch, T N Tozer
Journal of Chromatography
|
November 30, 1990
Simultaneous assay of pentachlorophenol and its metabolite, tetrachlorohydroquinone, by gas chromatography without derivatization
B G Reigner, J F Rigod, T N Tozer
Biochemical Pharmacology
|
July 1, 1976
Increased methotrexate toxicity due to concurrent probenecid administration
R E Kates, T N Tozer, D L Sorby
Pharmaceutical Research
|
August 1, 1992
Disposition, bioavailability, and serum protein binding of pentachlorophenol in the B6C3F1 mouse
B G Reigner, J F Rigod, T N Tozer
Therapeutic Drug Monitoring
|
September 1, 1989
Time for phenytoin concentration to peak: consequences of first-order and zero-order absorption
D L McCauley, T N Tozer, M E Winter
Journal of Pharmaceutical Sciences
|
January 1, 1975
Nonliner tissue disposition: salicylic acid in rat brain
M A Gonzalez, T N Tozer, T T Chang
Journal of Pharmaceutical Sciences
|
September 1, 1994
Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents
A D McLeod, D R Friend, T N Tozer
Human & Experimental Toxicology
|
May 1, 1993
Pentachlorophenol carcinogenicity: extrapolation of risk from mice to humans
B G Reigner, F Y Bois, T N Tozer
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1982
Urine flow-dependence of theophylline renal clearance in man
D D Tang-Liu, T N Tozer, S Riegelman
Page
of 9